prof. Guy Laureys
- ORCID iD
- 0000-0002-1708-4373
Show
Sort by
-
Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries
-
- Journal Article
- open access
A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic
-
Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis
-
Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre study
-
- Journal Article
- open access
Machine-learning-based prediction of disability progression in multiple sclerosis: An observational, international, multi-center study
-
- Journal Article
- A2
- open access
Comparative effectiveness of dimethyl fumarate versus non-specific immunosuppressants : real-world evidence from MSBase
-
- Journal Article
- A1
- open access
Inter-assay diagnostic accuracy of cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis
-
Routine CSF parameters as predictors of disease course in multiple sclerosis : an MSBase cohort study
-
- Journal Article
- A1
- open access
Vagus nerve stimulation enhances remyelination and decreases innate neuroinflammation in lysolecithin-induced demyelination
-
- Journal Article
- A1
- open access
Identification of DAGLA as an autoantibody target in cerebellar ataxia